| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jun Li | |
| Jian Gao | |||
| Liu-cheng Li | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 336-343 | |
| P577 | publication date | 2014-09-05 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | Functions of galectin-3 and its role in fibrotic diseases | |
| P478 | volume | 351 |
| Q64098409 | Adoptive Transfer of Bone Marrow-Derived Monocytes Ameliorates Schistosoma mansoni -Induced Liver Fibrosis in Mice |
| Q92278975 | Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8+ T-cells and galectin-3 in the liver |
| Q94465802 | An Integrated Approach Exploring the Synergistic Mechanism of Herbal Pairs in a Botanical Dietary Supplement: A Case Study of a Liver Protection Health Food |
| Q41334287 | Astragaloside IV Improves Bleomycin-Induced Pulmonary Fibrosis in Rats by Attenuating Extracellular Matrix Deposition |
| Q41663953 | Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats |
| Q64945372 | Clinical significance of galectin-3 expression in malformed hepatic venous tissue. |
| Q64917645 | Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH. |
| Q36708065 | Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens |
| Q40898595 | Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis |
| Q35842426 | Differential development of oil granulomas induced by pristane injection in galectin-3 deficient mice |
| Q89624987 | Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle |
| Q47119118 | Drugs and Targets in Fibrosis |
| Q90639151 | Early Hyperbaric Oxygen Treatment Attenuates Burn-Induced Neuroinflammation by Inhibiting the Galectin-3-Dependent Toll-Like Receptor-4 Pathway in a Rat Model |
| Q54373020 | Effects of 12 weeks of atorvastatin therapy on myocardial fibrosis and circulating fibrosis biomarkers in statin-naïve patients with hypertension with atherosclerosis. |
| Q92341061 | Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial |
| Q51061323 | Efficacy and safety of two dosages of canrenone as add-on therapy in hypertensive patients taking ace-inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE-IT trial. |
| Q26745566 | Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver Myofibroblasts |
| Q51008128 | Firefighting in viral myocarditis - Extinguish galectin-3 to control the inflamed heart? |
| Q104073447 | Foreign body responses in mouse central nervous system mimic natural wound responses and alter biomaterial functions |
| Q36025690 | Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis |
| Q50088162 | Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease. |
| Q36877769 | Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation |
| Q28069174 | Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis |
| Q64097454 | Galectin-3 as a prognostic biomarker for diabetic nephropathy |
| Q51313585 | Galectin-3 contributes to vascular fibrosis in monocrotaline-induced pulmonary arterial hypertension rat model. |
| Q52340243 | Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications. |
| Q38542678 | Galectin-3 in autoimmunity and autoimmune diseases |
| Q47679282 | Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity. |
| Q50126684 | Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus |
| Q49670112 | Galectin-3 regulation of wound healing and fibrotic processes: insights for chronic skin wound therapeutics |
| Q48159180 | Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z. |
| Q47898949 | Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet |
| Q42805774 | Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance. |
| Q48658707 | Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis |
| Q64045254 | Identification of galectin-3 as an autoantigen in patients with IgG-related disease |
| Q50998617 | In search of the magic bullet: can liver inflammation and fibrosis be reversed with medications? |
| Q38660742 | Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients |
| Q60938842 | JYYS Granule Mitigates Renal Injury in Clinic and in Spontaneously Hypertensive Rats by Inhibiting NF-B Signaling-Mediated Microinflammation |
| Q38871806 | Macrophages and galectin 3 play critical roles in CVB3-induced murine acute myocarditis and chronic fibrosis |
| Q90460347 | Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate Cancer |
| Q36885706 | Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis. |
| Q42175498 | New medical treatment strategies for nonalcoholic steatohepatitis |
| Q26738666 | Novel biomarkers for pulmonary arterial hypertension |
| Q46296067 | Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerization. |
| Q63379392 | Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease |
| Q30841381 | Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy |
| Q36306317 | Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population |
| Q37339791 | Prognostic value of plasma galectin-3 levels after aneurysmal subarachnoid hemorrhage |
| Q48035139 | Prospective Validation of a Screening Biomarker Approach Combining Amino-Terminal Pro-Brain Natriuretic Peptide With Galectin-3 Predicts Death and Cardiovascular Events in Asymptomatic Hemodialysis Patients |
| Q92876906 | Reference glycan structure libraries of primary human cardiomyocytes and pluripotent stem cell-derived cardiomyocytes reveal cell-type and culture stage-specific glycan phenotypes |
| Q41203031 | Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation |
| Q89818013 | Serum Galectin-3 level and recurrence of atrial fibrillation post-ablation - Systematic review and meta-analysis |
| Q41449179 | Serum galectin-3 levels and delirium among postpartum intensive care unit women. |
| Q38473640 | Strategies to prevent and reverse liver fibrosis in humans and laboratory animals |
| Q92130499 | The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children |
| Q39099711 | The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications. |
| Q90327530 | The impact of atrial fibrillation in patients with COPD during hospitalization |
| Q50068427 | The involvement of galectin-3 in skin injury in systemic lupus erythematosus patients |
| Q38945365 | Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease |
| Q51590827 | Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial-mesenchymal transition. |
| Q38776152 | Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects |
| Q40984224 | Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing Lgals3. |
| Q92294385 | Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH |
| Q58129418 | [Galectin-3 induces differentiation of rat bone marrow mesenchymal stem cells into hepatocyte-like cells] |
Search more.